Results 141 to 150 of about 35,486 (225)

The role of natural killer cells in adaptive immune responses [PDF]

Human natural killer (NK) cells have been shown to respond to numerous pathogenic stimuli, producing IFN-y as well as cytolytic effector molecules such as perforin and granzymes.
Horowitz, Amir
core   +1 more source

Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil. [PDF]

Emerg Infect Dis, 2023
Fernandes EG, Gomes Porto VB, de Oliveira PMN, Duarte-Neto AN, de Sousa Maia ML, Lignani LK, Nogueira JS, Teixeira GV, Iglezias SD, Blanco RM, Sato HK.   +10 more
europepmc   +1 more source

Travel and Yellow Fever Vaccine [PDF]

Journal of Travel Medicine, 2006
openaire   +2 more sources

Yellow Fever Vaccine-Related Neurotropic Disease in Brazil Following Immunization with 17DD. [PDF]

Vaccines (Basel), 2023
de Andrade Gandolfi F, Estofolete CF, Wakai MC, Negri AF, Barcelos MD, Vasilakis N, Nogueira ML.   +6 more
europepmc   +1 more source

Absence of transmission of vYF next generation Yellow Fever vaccine in mosquitoes. [PDF]

PLoS Negl Trop Dis, 2022
Bellone R, Mousson L, Bohers C, Mantel N, Failloux AB.   +4 more
europepmc   +1 more source

Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation. [PDF]

Lancet Microbe, 2023
Gould CV, Free RJ, Bhatnagar J, Soto RA, Royer TL, Maley WR, Moss S, Berk MA, Craig-Shapiro R, Kodiyanplakkal RPL, Westblade LF, Muthukumar T, Puius YA, Raina A, Hadi A, Gyure KA, Trief D, Pereira M, Kuehnert MJ, Ballen V, Kessler DA, Dailey K, Omura C, Doan T, Miller S, Wilson MR, Lehman JA, Ritter JM, Lee E, Silva-Flannery L, Reagan-Steiner S, Velez JO, Laven JJ, Fitzpatrick KA, Panella A, Davis EH, Hughes HR, Brault AC, St George K, Dean AB, Ackelsberg J, Basavaraju SV, Chiu CY, Staples JE, Yellow Fever Vaccine Virus Transplant and Transfusion Investigation Team.   +44 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Yellow Fever—More a Policy and Planning Problem than a Biological One

Emerging Infectious Diseases, 2016
Charles H. Calisher, John P. Woodall
doaj   +1 more source

A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine. [PDF]

NPJ Vaccines, 2022
Desai S, Anil K, Potey AV, Sindhu Y, Grappi S, Lapini G, Manney S, Tyagi P, Montomoli E, Poonawalla CS, Kulkarni PS.   +10 more
europepmc   +1 more source